George Tziras
Net worth: 247 036 $ as of 2026-06-29
Net worth: 247 036 $ as of 2026-06-29
Mr. George Tziras is a Chief Business Officer at Cybin, Inc. and a Chief Executive Officer & Director at Small Pharma, Inc. He is on the Board of Directors at Small Pharma, Inc. and Cybin UK Ltd. Mr. Tziras was previously employed as a Chief Business Officer & Director by Unilock Capital Corp.
He received his undergraduate degree from the University of Oxford and a graduate degree from The Paul H.
Nitze School of Advanced International Studies.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CYBIN, INC. 0.07% | 2026-07-12 | 37,373 ( 0.07% ) | 247 036 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| SMALL PHARMA INC. | Chief Executive Officer | 2022-07-19 |
| CYBIN INC. | Investor Relations Contact | - |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Director/Board Member | 2014-12-31 |
| Companies | Position | End |
|---|---|---|
| SMALL PHARMA INC. | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Paul H. Nitze School of Advanced International Studies
The Paul H. Nitze School of Advanced International Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Health Technology |
Unilock Capital Corp.
Unilock Capital Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Cybin, Inc.
Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Small Pharma, Inc.
Small Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuro pharmaceutical company that develops therapeutic treatments for mental health disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions